Home >  Investors Relations >  Financial Information >  News Releases

News Releases

  • December 1, 2017 at 5:04 PM EST
    ATLANTA , Dec. 1, 2017 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has completed its previously announced acquisition of JOTEC AG , a German-based, privately-held developer of
  • November 6, 2017 at 5:04 PM EST
    ATLANTA , Nov. 6, 2017 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that enrollment has started in the Company's BioGlue clinical trial in China.  The results from the trial will serve as
  • October 30, 2017 at 5:30 PM EDT
    ATLANTA , Oct. 30, 2017 /PRNewswire/ --  Third Quarter and Recent Highlights: Announced Definitive Agreement to Acquire JOTEC Accelerated Enrollment in PerClot Clinical Trial Achieved Third Quarter Revenues of $44.0 Million Achieved GAAP Net Income of  $1.3 million , or $0.04 Per Fully Diluted
  • October 17, 2017 at 5:04 PM EDT
    ATLANTA , Oct. 17, 2017 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that 2017 third quarter financial results will be released on Monday, October 30, 2017 after the market closes.  On
  • October 10, 2017 at 5:00 PM EDT
    Provides Access into $2 Billion Global Stent Graft Market with Highly Competitive Technologically Advanced Product Portfolio Adds Robust New Product Pipeline and Significantly Enhances R&D Capabilities Accelerates European Direct Strategy and Meaningfully Expands Cross-Selling Opportunities
  • October 2, 2017 at 8:04 AM EDT
    ATLANTA , Oct. 2, 2017 /PRNewswire/ --   CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced the appointment of Jeffrey H. Burbank to its Board of Directors effective September 29, 2017 .
  • September 18, 2017 at 8:34 AM EDT
    ATLANTA , Sept. 18, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that Pat Mackin , Chairman, President and Chief Executive Officer, will present at two investor conferences in
  • July 24, 2017 at 5:04 PM EDT
    ATLANTA , July 24, 2017 /PRNewswire/ -- Second Quarter Highlights: Revenues Increased Two Percent Year-over-Year to $47.8 Million ; Non-GAAP Revenues Increased Four Percent Year-over-Year Gross Margins were 69 Percent GAAP Net Income was $3.2 Million , or $0.09 Per Fully Diluted Common Share;
  • July 10, 2017 at 7:54 AM EDT
    ATLANTA , July 10, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2017 second quarter financial results will be released on Monday, July 24, 2017 after the market closes.  On Tuesday, July 25,
  • April 27, 2017 at 5:00 PM EDT
    ATLANTA , April 27, 2017 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming Deutsche Bank 42 nd Annual Health Care Conference on Wednesday, May 3, 2017 at the